Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.57 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.57 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | F2R | P25116 | 1/20 | 0.49 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.47 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.46 |
| ▸ | FEN1 | P39748 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18408979 | 0.87 | L3MBTL1 (0.58) | L3MBTL1NPSR1F2R | |
| SCHEMBL14036519 | 0.85 | L3MBTL1 (0.50) | TAS1R3TAS1R1TAS1R2L3MBTL1NPSR1 | |
| SCHEMBL18177833 | 0.83 | MEN1 (0.57) | TAS1R3TAS1R1TAS1R2F2RP2RX7 | |
| SCHEMBL28474196 | 0.81 | L3MBTL1 (0.49) | TAS1R3TAS1R1TAS1R2L3MBTL1NPSR1 | |
| SCHEMBL29643347 | 0.81 | L3MBTL1 (0.49) | TAS1R3TAS1R1TAS1R2L3MBTL1NPSR1 | |
| SCHEMBL15720276 | 0.78 | TAS1R3 (0.50) | TAS1R3TAS1R1TAS1R2F2RP2RX7 | |
| SCHEMBL4158170 | 0.77 | TAS1R3 (0.64) | TAS1R3TAS1R1TAS1R2F2RP2RX7 | |
| SCHEMBL14036676 | 0.76 | NPSR1 (0.60) | L3MBTL1NPSR1TSHRMEN1MAPK1 | |
| SCHEMBL13590979 | 0.76 | NPSR1 (0.64) | L3MBTL1NPSR1MEN1KMT2A | |
| SCHEMBL13985162 | 0.75 | NPSR1 (0.56) | L3MBTL1NPSR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | NUTECH VENTURES (US) | 2019-07-16 | — | — | US | disclosed |
| EP-0851790-A1 | THE APPLICATION OF DRY SPREADABLE WATER DISPERSIBLE GRANULE COMPOSITIONS | RHONE-POULENC INC. (US) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997004864-A1 | THE APPLICATION OF DRY SPREADABLE WATER DISPERSIBLE GRANULE COMPOSITIONS | RHONE-POULENC INC. (US) | 1997-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | FASN, LIPC, SREBF2 | TAS1R3 4829/4885TAS1R1 4816/4885TAS1R2 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.